Re: Discussion about Cures Acceleration Network and the President's Medical Countermeasures Initiative (MCMI) [ JJ erred in pointing you t ur domain and frankly, not a r NIH staff who d learn about litics around you have a ony sent me n detail to the [ should I reached out, ve mentioned oved to Richard thinks aying anything Ok, thanks. Will deflect. I was not asking to be involved in this stuff - it was just meant to be a casual conversation with one of our detailees... Rajesh On 11/18/10 9:14 PM, "Hudson, Kathy (NIH/OD) [E]" @nih.gov wrote: Thanks for asking. My knee jerk reaction is to support your misgivings. I > think it is a bad idea for a whole bunch of reasons. JJ erred in pointing you to the white house. Protocol dictates that we don't talk to the white house > without going through hhs. It would be okay to yak with one of our detailees but this has taken a turn. Plus, I suspect you know next to nothing about > biosecurity and BARDA. This is not really your domain and frankly, not a central issue to NCTS at the outset. It IS the domain of other NIH staff who > would probably be a little miffed about why you are suddenly in the middle of their "space." NIAID has programs in this arena and you should learn about > them but they ain't coming into to ncts at the get go and the politics around biosecurity is complex. > I would suggest to Richard that the meeting be "delayed" until you have a > better understanding of what Francis has in mind, yadda yadda. > > > -----Original Message-----

Reading Room Production, pp.216-217 · reading_room:email:00209

This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.

In context